These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intestinal absorption of SC4453 in the guinea-pig. Randimbivololona F; Lesne M Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):296-8. PubMed ID: 7165435 [No Abstract] [Full Text] [Related]
4. [Concentration of cardiac glycosides in the heart and brain (author's transl)]. Flasch H; Heinz N Arzneimittelforschung; 1976; 26(6):1213-6. PubMed ID: 989419 [TBL] [Abstract][Full Text] [Related]
5. Biliary excretion of cardiac glycosides. Russell JQ; Klaassen CD J Pharmacol Exp Ther; 1973 Sep; 186(3):455-62. PubMed ID: 4728329 [No Abstract] [Full Text] [Related]
6. [Therapeutic equivalence and inequivalence of chemically identical substances using cardiac glycosides for an example (author's transpl)]. Rietbrock N Arzneimittelforschung; 1976; 26(1A):135-46. PubMed ID: 947193 [TBL] [Abstract][Full Text] [Related]
7. [Study on the membrane permeability of cardiac using drugs (g-Strophantin, Digoxin and Oxyfedrin) micro-autoradiography in guinea pig heart]. Löhr E; Makoski HB; Göbbeler T; Strötges MW Arzneimittelforschung; 1971 Jul; 21(7):921-7. PubMed ID: 5109500 [No Abstract] [Full Text] [Related]
8. [Comparative studies on the uptake of cardiac glycosides by the cell]. Hüsten J; Ruiz-Torres A Verh Dtsch Ges Inn Med; 1969; 75():396-9. PubMed ID: 5400163 [No Abstract] [Full Text] [Related]
9. [Intestinal absorption of cardiac glycosides in vitro and in vivo]. Forth W; Furukawa E; Rummel W Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(1):53-72. PubMed ID: 4237042 [No Abstract] [Full Text] [Related]
10. [Metabolism and intestinal absorption of cardiac glycosides]. Lauterbach F Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):26-39. PubMed ID: 4896199 [No Abstract] [Full Text] [Related]
11. [Determination of the intestinal absorption of cardiac glycosides by measurement of 3H-labelled glycosides in the portal venous blood and in the intestinal lymph of cats]. Forth W; Furukawa E; Rummel W Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(4):406-19. PubMed ID: 4242055 [No Abstract] [Full Text] [Related]
13. [On the blood level and secretion of radioactively labeled cardiac glycosides following intraduodenal application in the cat]. Lahrtz H; Sattler RW; van Zwieten PA Z Gesamte Exp Med Einschl Exp Chir; 1968; 148(3):210-22. PubMed ID: 5728874 [No Abstract] [Full Text] [Related]
14. [On the determination of cardiotoxicity of cardiac glycosides in cats. 1. General bases and biophysical model for intravenous and intraduodenal infusion experiments]. Lenke D; Schneider B Arzneimittelforschung; 1969 May; 19(5):687-93. PubMed ID: 5819774 [No Abstract] [Full Text] [Related]
15. Effect of cardiac beta-adrenergic blockade or denervation on cardiotoxicity of digoxin and an aminosugar cardenolide. Puryear SK; Nash CB; Caldwell RW J Cardiovasc Pharmacol; 1981; 3(1):113-27. PubMed ID: 6160341 [TBL] [Abstract][Full Text] [Related]
16. [Metabolic degradation of 3H-labelled cardiac glycosides by the isolated perfused guinea pig liver]. Kolenda KD; Peters T Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):374-5. PubMed ID: 4253809 [No Abstract] [Full Text] [Related]